1451 The Domain III of the Japan Encephalitis Virus Envelope Protein, E DIII Protein>Others Japanese encephalitis virus:11072 1PJW Japanese encephalitis virus (JEV) is a major cause of acute viral encephalitis in both humans and animals. Domain III of the virus envelope glycoprotein (E DIII) plays an important role in the interaction of viral particles with host cell receptors to facilitate viral entry. In addition, DIII has been proposed to act as the binding region for the cellular receptor. 1452 BCR/ABL-expressing NIH3T3 mouse fibroblast cells Cell Mus musculus (Mouse):10090 1453 Amorphous Ni3B Inorganic molecules or materials None 1454 Crystalline Ni3B Inorganic molecules or materials None 1455 Fibroblast growth factor 1, FGF-1 Protein>Others P05230 Acidic fibroblast growth factor aFGF Endothelial cell growth factor ECGF Heparin-binding growth factor 1 HBGF-1 Homo sapiens (Human):9606 1AXM, 1DJS ,1DZC ,1DZD ,1E0O ,1EVT ,1HKN ,1JQZ ,1JT3 ,1JT4 ,1JT5 ,1JT7 ,1JTC ,1JY0 ,1K5U ,1K5V ,1M16 ,1NZK ,1P63 ,1PZZ ,1Q03 ,1Q04 ,1RG8 ,1RML ,1RY7 ,1YTO ,1Z2V ,1Z4S ,2AFG ,2AQZ ,2AXM ,2ERM ,2HW9 ,2HWA ,2HWM ,2HZ9 ,2K43 ,2K4A ,2K8R ,2KI4 ,2KI6 ,2LDN ,2NTD ,2Q9X ,2RQ9 ,3B9U ,3BA4 ,3BA5 ,3BA7 ,3BAD ,3BAG ,3BAH ,3BAO ,3BAQ ,3BAU ,3BAV ,3BB2 ,3CQA ,3CRG ,3CRH ,3CRI ,3CU1 ,3FGM ,3FJ8 ,3FJ9 ,3FJA ,3FJB ,3FJC ,3FJD ,3FJE ,3FJF ,3FJH ,3FJI ,3FJJ ,3FJK ,3HOM ,3JUT ,3K1X ,3O3Q ,3OJ2 ,3OJM ,3OJV ,3UD7 ,3UD8 ,3UD9 ,3UDA ,4J23 Acidic fibroblast growth factor (aFGF) is a member of the fibroblast growth factor family, originally isolated as mitogens for fibroblasts from the brain and pituitary. AFGF executes its pleiotropic biological actions by binding, dimerizing, and activating cell surface FGF receptors (FGFRs). The extra-cellular ligand-binding portion of FGFRs is composed of three immunoglobulin-like (Ig-like) domains (D1-D3). The crystal structure of the ectodomain of the FGFR complex with FGF demonstrated that the ligand-binding domain of FGFR involves Ig-like domains II and III (D2 and D3, respectively), as well as the linker between D2 and D3. 1456 Mixture of murine melanoma cell lines B16.F1 and B16.F10 Cell Homo sapiens (Human):9606 1457 Calcium silicate hydrate 0.66, C-S-H 0.66 Inorganic molecules or materials None C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix. 1458 Calcium silicate hydrate 1.0, C-S-H 1.0 Inorganic molecules or materials None C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix. 1459 Calcium silicate hydrate 1.5, C-S-H 1.5 Inorganic molecules or materials None C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix. 1460 Calcium silicate hydrate 1.7, C-S-H 1.7 Inorganic molecules or materials None C-S-H suspensions were prepared by reacting lime and silica in appropriate ratios in a stirred aqueous suspension. The name of the samples refers to the lime to silica ratio (Ca/Si) of the mix. 1461 Salivary pellicle Protein>Others Homo sapiens (Human):9606 In the oral cavity, the salivary proteins and peptides are selectively adsorbed to the enamel surface to form a us film called the acquired salivary pellicle. This pellicle is composed of peptides and (glycosylated) proteins, such as statherin, histatins, proline-rich proteins and mucins. 1462 Human umbilical vein endothelial cells, HUVECs Cell Homo sapiens (Human):9606 1463 IGVH1 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1464 IGVH3 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1465 IGVH4 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1466 IGVH6 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1467 IGVK1 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1468 IGVK2 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1469 IGVK3 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1470 IGVK4 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1471 IGVK5 template protein Protein>Polyclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1472 IGVK6 template protein Protein>Monoclonal antibody Homo sapiens (Human):9606 All consensus sequences from the 7 IGHV and 6 IGKV gene groups are found. The complementarity-determining region 3 gene derived from the pertuzumab (anti-HER2 humanized antibody) gene was used. Each gene was synthesized, and ligated using the overlapped PCR method. The designed Fv template was cloned into the pMALp4e (New England Biolabs Inc., Ipswich, MA) maltosebinding protein (MBP) fusion protein expression vector. 1473 Ephrin type-A receptor 2 Protein>Receptor Q03145 EC=2.7.10.1 Epithelial cell kinase Tyrosine-protein kinase receptor ECK Tyrosine-protein kinase receptor MPK-5 Tyrosine-protein kinase receptor SEK-2 Mus musculus (Mouse):10090 1474 Colonic adenomas Organ and tissue Mus musculus (Mouse):10090 1475 Envelope glycoprotein E2 Protein>Others P27958 [384-661] Hepatitis C virus genotype 1a (isolate H) (HCV):11108 1A1R, 1A1V, 1CWX, 1HEI, 1JR6, 1N1L, 1ONB, 1R7C, 1R7D, 1R7E, 1R7F, 1R7G, 1RGQ, 2A4R, 2F9V, 2HD0, 2JXF, 2KDR, 2O8M, 2OBO, 2OBQ, 2OC0, 2OC1, 2OC7, 2OC8, 2OIN, 2P59, 2QV1, 2XI2, 2XI3, 2XNI, 4CL1, 4JZN, 4JZO, 4MWF Full-length E2 protein extends from amino acids 384 to 746 of the HCV polyprotein and contains regions of extreme variability. E2661 is the C-terminal truncation of E2 at residue 661 (E2661).